Keyphrases
Environmental Lung Disease
100%
Airway Fibrosis
63%
Platelet-derived Growth factor-BB (PDGF-BB)
50%
Therapeutic Strategies
50%
Asthma
27%
Fibrosis
27%
Platelet-derived Growth Factor Receptor (PDGFR)
27%
Interstitial Pulmonary Fibrosis
22%
Interleukin-13 (IL-13)
22%
Mouse Model of Asthma
18%
Chronic Asthma
18%
Oxovanadium(IV)
18%
Inhaled Pollutants
18%
Inhaled Allergens
18%
Interstitial Fibrosis
18%
Growth Factor Signaling
13%
Chronic Lung Disease
13%
Pulmonary Fibrosis
13%
Mouse Model
9%
Lung Cells
9%
United States
9%
Vanadium
9%
Environmental Genetics
9%
Diabetes Therapy
9%
Bleomycin Mouse Model
9%
Ovalbumin Mouse Model
9%
Remodeling Process
9%
Fibrotic Scar
9%
Monoclonal Neutralizing Antibody
9%
Environmental Exposure
9%
STAT Transcription Factors
9%
Receptor Tyrosine Kinase Inhibitor
9%
Chronic Remodeling
9%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrosing Alveolitis
58%
Asthma
50%
Lung Disease
50%
Fibrosis
50%
Platelet Derived Growth Factor
45%
Platelet Derived Growth Factor Receptor
41%
Interleukin 13
41%
Mouse Model
29%
Chronic Lung Disease
12%
Lung Fibrosis
12%
Protein Tyrosine Kinase
8%
Disease
8%
Environmental Exposure
8%
Allergen
8%
STAT Protein
8%
Protein Tyrosine Kinase Inhibitor
8%
Ovalbumin
8%
Bleomycin
8%